Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1606 participants.

Also called NCT01385319

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,606 participants (enrolled count) (from the registry)
Sponsor
Marco Valgimigli (from the registry)
Registry
  • NCT NCT01385319
Other papers using this trial's data
  • Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial JACC. Cardiovascular interventions, 2016-03-14 DOI, PubMed 26965932
  • Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates Journal of the American College of Cardiology, 2015-03-03 DOI, PubMed 25720624

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Hungary, Italy, Portugal, Switzerland (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01385319. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
Acronym
ZEUS
Intervention (Device)
Bare metal stent implantation
Intervention (Device)
zotarolimus eluting stent
Lead sponsor
Marco Valgimigli (class: other)

Record details

Record id
cardio:ct-nct01385319
Content hash
e8805a583e1299e9ab42e494e1c3cd39ffc697a2f21f1925545b3e90180129c7